Becker Natasha S, Barshes Neal R, Aloia Thomas A, Nguyen Tuan, Rojo Javier, Rodriguez Joel A, O'Mahony Christine A, Karpen Saul J, Goss John A
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston TX 77030, USA.
Liver Transpl. 2008 Aug;14(8):1125-32. doi: 10.1002/lt.21491.
Two strategies to increase the donor allograft pool for pediatric orthotopic liver transplantation (OLT) are deceased donor segmental liver transplantation (DDSLT) and living donor liver transplantation (LDLT). The purpose of this study is to evaluate outcomes after use of these alternative allograft types. Data on all OLT recipients between February 2002 and December 2004 less than 12 years of age were obtained from the United Network for Organ Sharing database. The impact of allograft type on posttransplant survivals was assessed. The number of recipients was 1260. Of these, 52% underwent whole liver transplantation (WLT), 33% underwent DDSLT, and 15% underwent LDLT. There was no difference in retransplantation rates. Immediate posttransplant survivals differed, with WLT patients having improved 30-day patient survivals compared to DDSLT and LDLT patients (P = 0.004). Although unadjusted 1-year patient survivals were better for WLT versus DDSLT (P = 0.01), after risk adjustment, 1-year patient survivals for WLT (94%), DDSLT (91%), and LDLT (93%) were similar (P values > 0.05). Unadjusted allograft survivals were better for WLT and LDLT in comparison with DDSLT (P = 0.009 and 0.018, respectively); however, after adjustment, these differences became nonsignificant (all P values > 0.05). For patients < or = 2 years of age (n = 833), the adjusted 1-year patient and allograft survivals were also similar (all P values > 0.05). In conclusion, in the current era of pediatric liver transplantation, WLT recipients have better immediate postoperative survivals. By 1 year, adjusted patient and allograft survivals are similar, regardless of the allograft type.
增加小儿原位肝移植(OLT)供体同种异体肝移植库的两种策略是尸体供体节段性肝移植(DDSLT)和活体供体肝移植(LDLT)。本研究的目的是评估使用这些替代同种异体肝移植类型后的结果。2002年2月至2004年12月期间所有年龄小于12岁的OLT受者的数据来自器官共享联合网络数据库。评估了同种异体肝移植类型对移植后生存率的影响。受者人数为1260人。其中,52%接受了全肝移植(WLT),33%接受了DDSLT,15%接受了LDLT。再次移植率没有差异。移植后即刻生存率有所不同,WLT患者的30天患者生存率高于DDSLT和LDLT患者(P = 0.004)。虽然未经调整的WLT患者1年患者生存率优于DDSLT(P = 0.01),但在进行风险调整后,WLT(94%)、DDSLT(91%)和LDLT(93%)的1年患者生存率相似(P值>0.05)。与DDSLT相比,WLT和LDLT的未经调整的同种异体肝移植生存率更好(分别为P = 0.009和0.018);然而,调整后,这些差异变得不显著(所有P值>0.05)。对于年龄≤2岁的患者(n = 833),调整后的1年患者和同种异体肝移植生存率也相似(所有P值>0.05)。总之,在当前小儿肝移植时代,WLT受者术后即刻生存率更好。到1年时,无论同种异体肝移植类型如何,调整后的患者和同种异体肝移植生存率相似。